Location
Suwanee, GA
Start Date
6-5-2025 1:00 PM
End Date
6-5-2025 4:00 PM
Description
Introduction: GLP-1 receptor agonist medication usage has seen a rapid increase in usage not only for diabetic patients but now for obese and overweight patients who are searching for alternative weight loss methods. Although these medications are proving useful for helping patients lose weight, there are notable side effects that patients need to consider.
Methods: A retrospective case-control study was conducted using data from the NIH All of Us database. Patients were included based on the diagnosis of overweight and obesity. Patients were excluded based on diagnosis of type 1 or type 2 diabetes mellitus, A1c > 6.5 and diagnosis of conditions that would increase the risk of fragility fracture.
The correlations between use of GLP-1 agonist drugs and side effects, specifically risk of bone fractures, will be analyzed and discussed.
Embargo Period
5-28-2025
Included in
GLP1 Receptor Agonist Increases Fracture Risk In Patients with Obesity
Suwanee, GA
Introduction: GLP-1 receptor agonist medication usage has seen a rapid increase in usage not only for diabetic patients but now for obese and overweight patients who are searching for alternative weight loss methods. Although these medications are proving useful for helping patients lose weight, there are notable side effects that patients need to consider.
Methods: A retrospective case-control study was conducted using data from the NIH All of Us database. Patients were included based on the diagnosis of overweight and obesity. Patients were excluded based on diagnosis of type 1 or type 2 diabetes mellitus, A1c > 6.5 and diagnosis of conditions that would increase the risk of fragility fracture.
The correlations between use of GLP-1 agonist drugs and side effects, specifically risk of bone fractures, will be analyzed and discussed.